ArticleKidney international2022
Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer.
Open access · bronzeAbstract read
In one paragraph
Article in Kidney international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.
- Incidence and risk factors of acute kidney injury in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.Frontiers in immunology · 2023Pooled it
- The differentiation and intervention strategies for acute kidney injury after or induced by immune checkpoint inhibitors.American journal of cancer research · 2025Review
- Immunohistochemical Evaluation of Renal Biopsy with Anti-PD1 and p53 to Solve the Dilemma between Platinum- and Pembrolizumab-Induced AKI: Case Report and Review.Journal of clinical medicine · 2024Article
- Immunotherapy in oncology and the kidneys: a clinical review of the evaluation and management of kidney immune-related adverse events.Clinical kidney journal · 2023Review
- Clinicopathological Features of Kidney Injury Related to Immune Checkpoint Inhibitors: A Systematic Review.Journal of clinical medicine · 2023Review
- Onconephrology 2022: An Update.Kidney360 · 2023Review
- Prediction Models and Prognostic Analysis of Immune-Related Acute Kidney Injury in Lung Cancer Patients.Technology in cancer research & treatmentArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
37 authors at 20 institutions in 10 countries.
Shruti GuptaDivision of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Ian A StrohbehnDivision of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Qiyu WangDivision of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Paul E HannaDivision of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Rituvanthikaa SeethapathyDivision of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Jason M ProsekDivision of Nephrology, Department of Internal Medicine, the Ohio State University, Columbus, Ohio, USA.
Sandra M HerrmannDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Ala AbudayyehDivision of Internal Medicine, Section of Nephrology, the University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
A Bilal MalikDivision of Nephrology, University of Washington, Seattle, Washington, USA.
Sebastian LoewDepartment of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Christopher A CarlosDepartment of Medicine, Division of Nephrology, University of California San Francisco, San Francisco, California, USA.
Wei-Ting ChangDepartment of Clinical Medicine, Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Department of Internal Medicine, Division of Cardiology, Chi-Mei Medical Center, Tainan, Taiwan; Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan.
Pazit BeckermanInstitute of Nephrology and Hypertension, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel.
Zain MithaniKatz Family Division of Nephrology and Hypertension, University of Miami Miller School of Medicine, Miami, Florida, USA.
Chintan V ShahDepartment of Medicine, Division of Nephrology, Hypertension, and Renal Transplant, University of Florida, Gainesville, Florida, USA.
Amanda D RenaghanDivision of Nephrology, University of Virginia Health System, Charlottesville, Virginia, USA.
Sophie de SeigneuxService of Nephrology, Department of Medicine, University Hospital of Geneva, Geneva, Switzerland.
Luca CampedelDepartment of Medical Oncology, Assistance Publique-Hôpitaux de Paris (AP-HP), Sorbonne Université, Hôpital Pitié-Salpêtrière, Institut universitaire de cancérologie, CLIP Galilée, Groupe de Recherche Interdisciplinaire Francophone en Onco-néphrologie (GRIFON), Paris, France.
Abhijat KitchluDivision of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Daniel Sanghoon ShinDepartment of Medicine, Division of Hematology-Oncology, Veterans Affairs Greater Los Angeles Healthcare System (VAGLAHS), David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, California, USA.
Gaia CoppockRenal-Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Nuttha LumlertgulDepartment of Critical Care, Guy's & St Thomas Hospital, London, UK; Division of Nephrology, Faculty of Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Pablo GarciaDivision of Nephrology, Stanford University School of Medicine, Palo Alto, California, USA.
David I Ortiz-MeloDivision of Nephrology, Duke University Medical Center, Durham, North Carolina, USA.
Arash RashidiDivision of Nephrology and Hypertension, University Hospital Cleveland Medical Center, Cleveland, Ohio, USA.
Ben SprangersDepartment of Microbiology, Immunology and Transplantation, Laboratory of Molecular Immunology (Rega Institute for Medical Research), KU Leuven, Leuven, Belgium; Division of Nephrology, University Hospitals Leuven, Leuven, Belgium.
Vikram AggarwalDepartment of Nephrology and Hypertension, Northwestern University and Feinberg School of Medicine, Chicago, Illinois, USA.
Karolina BenesovaDepartment of Medicine V, Hematology, Oncology, and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
Kenar D JhaveriDivision of Kidney Diseases and Hypertension, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Great Neck, New York, USA.
Frank B CortazarNew York Nephrology Vasculitis and Glomerular Center, Albany, New York, USA.
Astrid WeinsDepartment of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Yiqin ZuoDepartment of Pathology and Laboratory Medicine, University of Miami, Miami, Florida, USA.
Meghan J MooradianDivision of Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Kerry L ReynoldsDivision of Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
David E LeafDivision of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Meghan E SiseDivision of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, USA. Electronic address: msise@partners.org.
ICPi-AKI Consortium
Massachusetts General Hospital · USBrigham and Women's Hospital · USUniversity of Miami · USUniversity of California, Los Angeles · USMayo Clinic · USNorthwell Health · USNorthwestern University · USUniversity Health Network · CAUniversity of California, San Francisco · USUniversity of Virginia Health System · USDuke Medical Center · USHeidelberg University · DESorbonne Université · FRTel Aviv University · ILThe University of Texas MD Anderson Cancer Center · USUniversity Hospitals of Cleveland · USUniversity of Washington · USKing Chulalongkorn Memorial Hospital · THRega Institute for Medical Research · BEStanford University · US
Funding
Tracking and Evaluation CoreU54GM115428 · NIGMS · UNIVERSITY OF MISSISSIPPI MED CTR · PI HALL, JOHN E · 2016 to 2025
$38.2MProtection of kidney from autoimmunity by modulating co-stimlatory signalingK08DK120868 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI MURAKAMI, NAOKA · 2019 to 2023
$886kNIDDK NIH HHS K08 DK120868NIGMS NIH HHS U54 GM115428
Abstract
PubMed holds no abstract for this paper.
Indexed as
Acute Kidney InjuryLung NeoplasmsAntibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsHumansAntibodies, Monoclonal, Humanizedpembrolizumab
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.